Panel on Guilford sNDA canceled

The FDA's Oncologic Drugs Advisory Committee (ODAC) meeting to review GLFD's sNDA for Gliadel was canceled. The committee was slated to consider the sNDA on Tuesday, Sept. 11 (see BioCentury Extra, M...